IAA
ABOS icon

Independent Advisor Alliance’s Acumen Pharmaceuticals ABOS Stock Holding History

Independent Advisor Alliance’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7K Hold
19,000
– – ﹤0.01% 1030
2026
Q1 		$44.8K Hold
19,000
– – ﹤0.01% 1566
2025
Q4 		$40.1K Buy
+19,000
New +$37.7K ﹤0.01% 980

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Independent Advisor Alliance's ABOS Position: Q2 2026 in Review

Independent Advisor Alliance held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 19,000 shares worth $50.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Independent Advisor Alliance first reported a position in ABOS in Q4 2025 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Independent Advisor Alliance held 19,000 shares of Acumen Pharmaceuticals worth $50.7K as of Q2 2026.
  • Independent Advisor Alliance left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Independent Advisor Alliance's portfolio in Q2 2026, its #1030 holding.
  • Independent Advisor Alliance first reported a position in Acumen Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.